UHPLC Analysis of Flakka Compounds on Ascentis® Express HILIC
材料
相关产品
产品编号
说明
价格
3,4-Methylenedioxypyrovalerone HCl (MDPV) solution
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®MDPBP hydrochloride solution
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®Naphyrone hydrochloride
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®α-Pyrrolidinovalerophenone hydrochloride solution
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®α-Pyrrolidinopropiophenone hydrochloride solution
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®CONDITIONS
column
Ascentis Express HILIC, 10 cm x 2.1 mm I.D., 2 μm (51409-U)
mobile phase
10 mM ammonium formate in acetonitrile:water (95:5)
flow rate
0.4 mL/min
column temp.
35 °C
detector
UV, 265 nm
injection
1 μL
sample
50 μg/mL in methanol:acetonitrile (10:90)
说明
分析说明
The rapid separation of the street drug Flakka (α-PVP) and related compounds is shown here on an Ascentis Express HILIC column. Highest grade UHPLC solvents were used to supply low background interference and low particulate contamination for robust, trouble-free operation. Cerilliant CRMs provided reliable identification and quantification.
法律信息
Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany